LONDON--(BUSINESS WIRE)--The global oral cancer therapeutics market size is poised to reach USD 1.04 billion by 2023, according to a new report by Technavio, progressing at a CAGR of over 8% during the forecast period.
Read the 151-page research report with TOC on " Oral Cancer Therapeutics Market Analysis Report by Product (targeted therapy and chemotherapy) and geographical regions (North America, Europe, Asia, and ROW) 2019 - 2023". Request Free Sample Pages
The market is driven by the growing awareness about oral cancer. In addition, increasing incidence and prevalence of oral cancer is anticipated to further boost the oral cancer therapeutics market during the forecast period.
Currently, several public and private organizations are taking initiatives to increase awareness about oral cancer by providing information on the risk factors as well as the signs and symptoms of various oral diseases. This is expected to drive the overall growth of the oral cancer therapeutics market.
Furthermore, the global oral cancer therapeutics market has witnessed the development of new therapeutics and increasing advances in the diagnostic modalities of oral cancer. The number of new cases of oral cancer has increased significantly in recent years. Despite the availability of chemotherapy and targeted therapy, the mortality rate has also increased due to the lack of diagnosis of cancer in its early stages. Therefore, the increase in prevalence and mortality rate of oral cancer has resulted in a huge unmet need for therapeutics in the market. This will attract pharmaceutical vendors to enter the market with novel therapies, thereby driving the oral cancer therapeutics market growth.
For More Information: Request Free Sample Pages
The report includes detailed profiles of the leading companies & prominent vendors of the market:
- AstraZeneca Plc
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- Endo International Plc
- F. Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- Mylan NV
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
Market Segmentation by Category and Product Types:
The Oral Cancer Therapeutics Market can be broadly categorized into the following product segments:
- Targeted therapy
- Chemotherapy
Key Regions for the Oral Cancer Therapeutics Market:
Featuring a breakdown of region wise market shares until 2019.
- North America
- Europe
- Asia
- ROW
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
-
Market segmentation analysis
Market Sizing
- Market definition
-
Market size and forecast
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Healthcare Market are:
Clinical Reference Laboratory Services Market – Global Clinical Reference Laboratory Services Market by application (clinical chemistry, human and tumor genetics, medical microbiology and cytology, and other esoteric tests), end-users (hospitals and private clinics, corporate offices and companies, and government entities), service (standalone reference laboratories, hospital-based reference laboratories, and clinic-based reference laboratories), and geography (Asia, Europe, North America, and ROW).
Suture Anchor Market – Global Suture Anchor Market by type (knotted suture anchors and knotless suture anchors), material (biocomposite suture anchors, PEEK suture anchors, metallic suture anchors, bioabsorbable suture anchors, and others), and geography (Asia, Europe, North America, and ROW).
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
